Twist Bioscience guides to 21 percent growth in 2027
Twist Bioscience reported record fiscal 2026 revenue of 459.4 million dollars, up 22 percent, and guided fiscal 2027 revenue to 550 million to 560 million dollars.
Every story, newest first.
Twist Bioscience reported record fiscal 2026 revenue of 459.4 million dollars, up 22 percent, and guided fiscal 2027 revenue to 550 million to 560 million dollars.
Mercer International filed a prepackaged Chapter 11 case on November 9 to cut its funded debt from 1.64 billion dollars to about 700 million dollars by the end of the year.
Benitec reported a 100 percent responder rate for BB-301, Prime Medicine closed a 143.7 million dollar offering, Yarrow raised 172.5 million dollars, and three FDA goal dates passed on Saturday with no decision published.
A UN rapporteur used the Francophonie summit in Phnom Penh to press Cambodia on detained activists, and a Federal Register notice published the names from OFAC's November 4 Iran designations.
The Francophonie summit opened in Phnom Penh on Sunday with DR Congo having withdrawn its candidate for secretary-general and backed Romania's Dacian Ciolos, while Rwanda kept incumbent Louise Mushikiwabo in the race ahead of Monday's leadership vote.
Cape Verdeans voted on Sunday in a presidential election pitting incumbent Jose Maria Neves, seeking a second term, against five challengers including Joana Rosa, the first woman to run for president since independence in 1975.
Saudi Arabia's annual inflation eased to 1.7 percent in October from 1.9 percent in September, GASTAT reported on November 15.
Saudi livestock output rose in 2025 on GASTAT data, Bank of Canada Deputy Governor Gravelle speaks on November 18, and Fed and Banxico minutes land this week.
Klaas Knot, a leading contender to lead the ECB, said the bank should contain disorderly bond spreads but cannot fix unsustainable fiscal policy.
The 81 Collection announced an additional close of its second fund at $82 million on November 11, and Australia's Firmus Grid is reported to be pursuing a $3 billion private raise after withdrawing its IPO last month.